Solid Tumors


FDA Updates: Assays Used in Cancer Care Get Green Light

August 09, 2020

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations

June 30, 2020

FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.

Payers Should Take Action on Rising NSCLC Costs

November 29, 2019

A new report outlines the sharp cost increase associated with a NSCLC drug’s move from second-line to first-line treatment, and suggests payers work with manufacturers to address treatment pricing.

Chemotherapy Remains Significant for Cancer Treatment

November 29, 2019

Chemotherapy may be the “boomer” to millennial-esque new cancer treatments, but there is a reason the old standard became that way, and isn’t likely to be replaced anytime soon.

Personalized Treatments Could Increase Value of Cancer Care

November 25, 2019

There are a lot of ideas about ways to increase the value of cancer care, but personalized treatments may be the most significant and immediate.  

Collaboration Key to a Holistic Model of Cancer Care

November 25, 2019

A holistic approach provides value and creates plans that support the wide-ranging needs of cancer patients and their families.

Radiation Oncology Model: What You Need to Know

November 04, 2019

As the proposed Radiation Oncology Model innovative payment model looms on the horizon, Anne Hubbard, director of health policy for the American Society for Radiation Oncology, talks about the main elements and complex finer points of the model, as well as what it will take for its success.

Altering Drug Dosages Can Benefit Patient’s Pockets

October 31, 2019

Researchers suggest changing cancer drug regimens could save money without sacrificing quality.

Planning For Oncology Care Model 2.0 is Underway

October 30, 2019

Proposed as an alternative to CMS’ Oncology Care Model, the Community Oncology Alliance is developing its Oncology Care Model 2.0 with the hopes of creating a better, more efficient payment and treatment system for cancer care.

Accurate Response Assessments Vital to Cancer Treatments

October 30, 2019

In order to develop more effective cancer treatments, researchers are turning to precision medicine to evaluate patient tumor responses.

Managing the Financial Fallout of Cancer Care

October 12, 2019

The high cost of targeted cancer therapies creates a “financial toxicity” for patients that has crippling effects. 

The Immeasurable Benefits of Palliative Cancer Care

October 11, 2019

Palliative care offers value and patient-centered care to lung cancer patients.

Mandatory Radiation Oncology Payment Model on Horizon

October 09, 2019

The CMS-proposed Medicare model would offer set bundled payments, regardless of setting.

Five Ways Oncology Has Become More Personalized

September 23, 2019

Cancer treatment is becoming more personalized. Here’s how.

Championing Community Support, Privacy in Cancer Care Facilities

September 22, 2019

Oncological facilities that promote flexibility are the ones best suited to care for the needs of their patient population.

Innovative Staff Areas––A Critical Component for More Impactful Cancer Care

September 21, 2019

Optimizing the nursing function is a key design consideration to improve the patient experience and patient-reported outcomes

Better Design to Help Ease a Parent’s Worst Nightmare

September 18, 2019

Simple design considerations at St. Jude Children's Research Hospital make a positive impact on loved ones.

FDA Urges Inclusion of Males in Breast Cancer Studies

September 16, 2019

Because the disease in males is rare, they have historically been excluded from clinical trials of breast cancer drugs.

Top Women’s and Men’s Cancer Treatment Developments

September 13, 2019

From breast cancer to prostate cancer, the state of oncology care and how it will evolve.

Bringing Value to Cancer Care

July 25, 2019

How a tool is helping execs define and measure value in oncology.